The following post comes from Tuan Tran, a rising 3L at Scalia Law and a Research Assistant at C-IP2. Click on image for full-size PDF flyer. Small ideas can lead […]
[Archived Post] Panel Discussion: Vaccines, Intellectual Property, and Global Equity
The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at C-IP2. The COVID-19 pandemic has shined a spotlight on the role of intellectual […]
[Archived Post] A View from Both Sides: COVID-19, the TRIPS Waiver, IP Rights, and How to Increase the Supply of Vaccines
Issue The United States and other wealthy nations have access to plenty of COVID-19 vaccine doses and thus are beginning to get the pandemic under control, while less affluent countries […]
[Archived Post] Creative Upstarts and Startups: How IP Creates Opportunities and Opens Doors
By Maryna Koberidze This is the first in a series of posts summarizing CPIP’s 2016 Fall Conference, “Intellectual Property & Global Prosperity.“ The conference was held at Antonin Scalia Law […]
[Archived Post] How IP-Fueled Innovations in Biotechnology Have Led to the Gene Revolution
We’ve released a new issue paper, The Gene Revolution, by Amanda Maxham, a research associate and writer at the Ayn Rand Institute. Dr. Maxham explores how innovations in biotechnology, enabled […]
[Archived Post] Intellectual Property, Innovation and Economic Growth: Mercatus Gets it Wrong
By Mark Schultz & Adam Mossoff A handful of increasingly noisy critics of intellectual property (IP) have emerged within free market organizations. Both the emergence and vehemence of this group […]